Sign Up to like & get
recommendations!
1
Published in 2017 at "European Journal of Immunology"
DOI: 10.1002/eji.201747248
Abstract: Dendritic cells (DC) are specialized in the processing and presentation of antigen for the activation of lymphocytes. Multiple subsets of DCs exist with distinct functions and roles in the initiation of immune responses. DCs found…
read more here.
Keywords:
dcs;
lymph;
dendritic cells;
antigen ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-93113-y
Abstract: Anti-PD-L1 antibodies benefit many cancer patients, even those with “non-inflamed tumor”. Determining which patients will benefit remains an important clinical goal. In a non-inflamed tumor mouse model, we found that PD-L1 was highly expressed on…
read more here.
Keywords:
cxcr3;
response;
atezolizumab;
cell priming ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2021-003264
Abstract: Tumor-targeted CD40 agonism represents an attractive strategy for cancer immunotherapy (CIT) as it promotes dendritic cell (DC) activation and concomitant tumor-specific T cell priming without causing systemic side effects. We developed the bispecific CD40 agonistic…
read more here.
Keywords:
cea cd40;
cell priming;
cea;
tumor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.879648
Abstract: Background Decoy receptor 3 (DcR3) belongs to the tumor necrosis factor (TNF) receptor superfamily and neutralizes TNF ligands, including FasL and TRAIL, to prevent T activation during T-cell priming. However, the cellular mechanisms underlying acute…
read more here.
Keywords:
cell;
dcr3;
acute cell;
cell priming ... See more keywords